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Abstract The true incidence of inverted papilloma (IP) is
not yet known. From hospital-based studies, its incidence
has been estimated to approximately 0.5/100,000 person
years. Earlier hospital case studies have shown that IP can
undergo a malignant transformation in 1–53 %. The fre-
quency of its malignant transformation on a population
basis is unknown. To our knowledge, no standardised
incidence ratio (SIR) has been reported for malignancies
among IPs. This study aims to investigate these incidences
on a population basis. Using the data from the Swedish
Cancer Registry (SCR), we have identified patients with IP
and patients with Squamous Cell Carcinoma (SCC) diag-
nosed between 1960 and 2010 in Sweden. Incidence of IP
and incidence of SCC among patients with IP and SIR were
analyzed. Eight hundred and fourteen patients with IP were
identified. The incidence of IPs reported to the SCR
increased from 1960 to 2010. In this cohort, SCC was
overrepresented, as compared with the general population.
The incidence of IP in the Swedish population seems to
have increased.
Keywords Inverted papilloma  Squamous cell
carcinoma  Neoplastic cell transformation  Incidence 
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Introduction
Inverted papilloma (IP), often referred to as schneiderian
papilloma, is a locally destructive benign tumour of the
sino-nasal mucosa with a tendency for malignant trans-
formation and a high propensity for recurrence [1–3]. It
arises from the transitional epithelium, the Schneiderian
membrane. Histologically, IP typically comprises both
exophytic and endophytic components. The tumour
invaginates into the underlying tissue, hence its name [4].
The true incidence of IP is not yet known, nor is its incidence
pattern over time. From hospital-based studies, the incidence has
been estimated to approximately 0.5/100,000 person years
[1, 5, 6]. Most patients are diagnosed in their 60s with a male
predominance of 2–10:1 [7, 8]. Earlier hospital case studies have
shown that IP undergoes a malignant transformation in 1–53 %
[9, 10]. The frequency of its malignant transformation on a
population basis is unknown. To our knowledge, no standard-
ised incidence ratio (SIR) has been reported for malignancies
among IPs. The malignancies can occur synchronously, diag-
nosed in the same initial lesion, or metachronously, arising in the
same area where the IP had previously been removed. In the
literature, synchronous cancers are more frequent [11].
The aim of the present population-based cohort study was
to establish the incidence of IP over time in the Swedish
population as well as the risk of concomitant and later
malignancies in the sino-nasal mucosa in patients with IP.
Materials and methods
Subjects
The Swedish Cancer Registry (SCR) covers the whole
Swedish population, today approximately nine million
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people. All malignant tumours as well as some precan-
cerous tumours, comprising IP, are reported to the SCR
since 1958. The reliability of the SCR is high and the
reporting to SCR is estimated to over 96 %, at least
regarding true malignant neoplasms [12, 13]. Approxi-
mately, 99 % of the cases are morphologically verified
[12]. The SCR reports cases using the ICD-7. Clinical
diagnoses according to ICD-8 to ICD-10 have been trans-
formed to ICD-7 in the register.
From the SCR, we included all tumours in the sino-nasal
area, numbered 160.0, 160.2, and 160.7–160.9, according
to the ICD-7, with a histological code for true papillomas.
We chose to include patients reported to the SCR with IP
since 1960, since the reporting to the register is considered
reliable since 1960 [13]. Through the data from SCR, we
were able to identify other information, such as gender
distribution and age, at diagnosis (Table 1). In a similar
way, we also retrieved data about those patients who were
diagnosed with an SCC in the sino-nasal mucosa.
Statistics
Using the emigration and immigration registers from
Statistics Sweden, we were able to identify patients lost to
follow-up. Data concerning the size of the population and
its age and sex distributions from year to year were also
given by Statistics Sweden.
Because of the rarity of IP, we chose to report its inci-
dence per decade. The calendar period was divided into
decades beginning in 1960. Incidence rates were calculated
by dividing the number of cases in each calendar period by
the total average population in each age group in respective
calendar period. The incidence rates were calculated for the
whole population as well as sex specific. For comparison,
the rates are also age-adjusted to the Swedish Standard
Population of year 2000.
The risk of developing cancer among patients with IP
was calculated as a proportion and a standardised incidence
ratio (SIR). SIRs were calculated for SCC in patients
diagnosed with IP by dividing the observed numbers of
SCC in this group by the expected numbers of SCC based
on person years at risk and population incidence.
Statistical analysis was done in SAS 9.2, STATA, and
Excel.
The study was approved by the Ethical Committee at the
Karolinska Institute, Stockholm, Sweden, according to the
ethical permission 2012/49-31/2.
Results
The mean age of diagnosis for IP was 55.1 (54.7 in male
patients and 56.1 for women). No trend was seen over time
(Table 1).
The male-to-female ratio in the 60s was 1:1, but only six
cases were reported. The male-to-female ratio was rather
constant over time from the 70s, 2.4–3.3:1 with no time-
dependent trend. The incidence of IP increased over time
with a substantial leap from the 60s when the incidence
was 0.01/100,000 py (person years), to the 70s when the
incidence was 0.07/100,000 py, and from the 70s to the 80s
when the incidence was 0.29/100,000 py. After a smaller
decrease during the 90s, i = 0.23/100,000 py, the inci-
dence has again increased during the first decade of the
twenty-first century to 0.33/100,000 py (Fig. 1). The same
trend was seen in male and females.
Of all the persons who were diagnosed with IP,
n = 814, 11 were diagnosed with SCC or SCC in situ
which corresponds to a proportion of 1.35 % (Table 2).
This represents an incidence of SCC over the whole time
period of 111/100,000 py among patients with IP as com-
pared with 0.37/100,000 py in the general population. Only
in the male population did the IPs undergo a malignant
transformation, which is a statistically significant
Table 1 Characteristics of patients with IP and SCC in Sweden
1960–2010
1960’s 1970’s 1980’s 1990’s 2000’s Total
IP
N men 3 36 165 148 232 584
Mean age 40.7 57.6 52 54.9 56.3 54.7
N women 3 15 69 48 95 230
Mean age 47.7 54 55.9 52 59 56.1
N total 6 51 234 196 327 814
Mean age 44.2 56.5 53.1 54.2 57.1 55.1
Men/women 1 2.4 2.4 3.1 2.5 2.5
SCC
Total 1 4 6 11
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Fig. 1 Incidence of inverted papilloma/100,000 py, age-adjusted
Sweden, per decade
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(p\ 0.05) difference compared with women. Among men
with IP, the proportion developing SCC was 1.88 % with
an incidence of 157.8/100,000 py as compared with 0.46/
100,000 py in the general male population.
For the whole IP cohort, SIR was 142.76 with a p value
\0.05, thereby also showing an over-representation of
SCC among patients with IP. When analyzing the SIR
stratified by duration, we found no evidence of reverse
causality (Table 3).
We did not find that patients with IP had a higher risk of
developing sino-nasal malignancies of other histological
types than SCC compared with the general population (data
not shown).
Discussion
In this population-based study, we found that during the
study period, the age standardised incidence of IP increased
by approximately 400 %, from 0.01 to 0.33/100,000 py.
The SIR of 142.76 showed a large over-representation of
SCC among patients with IP (p\ 0.005). Interestingly, the
malignant transformation only occurred in men, repre-
senting a proportion of 1.88 % among men with IP. This
represents a 300-fold increased risk as compared with the
general male population.
In our study, two persons (18 %) with IP had synchronous
SCC and nine (82 %) had metachronous SCC. Although our
study was population based, our results regarding the inci-
dence of IP are well in line with hospital data presented in
Denmark [1, 14] and in the European position paper on the
endoscopic management of tumours of the nose, paranasal
sinuses, and skull base conducted by Lund et al. [15].
There are, however, some differences, where we found an
age standardised incidence of 0.29 in the 80’s, whereas in
Denmark, the incidence was 0.52 during approximately the
same time period. This could be due to hazard but may also
show the advantage of a higher coverage in a population-
based study, or less accurate histopathological diagnosis.
In contrast to malignant sino-nasal tumours (malignant
melanoma excluded) which have decreased over the decades
[16], we found an increase of IP over time: In the 60’s, the
incidence was very low (0.008), but from the 70’s, there has
been a fivefold increase (0.006–0.033), an increase which has
not been shown earlier. This may be a true increase. However,
this could very possibly be due to underreporting during the
earlier part of the study period and the possibility that over time
more sino-nasal biopsies were sent for pathological assessment
and diagnosis. The accuracy in the Swedish Cancer registry
has been investigated for common, malignant tumours. IP is
considered a precancerous lesion and the reporting rate may,
therefore, be lower than for true malignant lesions, especially
in the beginning of the study period. The increase is possibly
also related to the detecting of IP due to a higher awareness of
IP among ENT physicians and in their use of endoscopic sinus
surgery. The preciseness of the histopathological evaluation
has improved and may have lead to an increased reporting to
the cancer register. The increase may also be correlated to a,
until now, not fully identified environmental factor.
Earlier studies have reported diverging results concerning
the risk of malignant transformation of 1–53 %, most of
which are considerably higher than the 1.35 % that we
found in our population-based study [8–10, 17, 18]. This
discrepancy may be due to that earlier hospital-based studies
from referral centres have dealt with patients with larger or
recurrent IP tumours and that earlier studies, not based on a
register with complete coverage of the population, (such as
the SCR), have not included all IPs. It may also be due to
differences in studied populations. Another plausible cause
for the higher risk of malignant transformation in the pre-
vious studies is the likely underreporting of well-differenti-
ated SCC ‘‘ab initio’’. However, percentage does not allow
comparison between studies on different populations, since
difference in age or gender distribution is not known.
Hopefully, future studies will be conducted presenting SIRs
in other regions allowing a better comparison.
Table 2 Sex distribution of
patients with IP and, among
them, with SCC in Sweden
1960–2010
N women N men
IP 230 589
SCC 0 11
N women number of women
diagnosed with IP and among
them SCC, N men number of
men diagnosed with IP and
among them SCC
Table 3 SIR of SCC in
patients with IP stratified by
duration of IP
N Duration Expected Outcome SIR SIRL SIRU p
1 3–4 years 0.013621 1 73.42 1.86 409.06 0.0773
2 5–9 years 0.019131 3 156.81 32.34 458.28 0.0014
3 More than 10 years 0.037111 4 107.78 29.37 275.97 0.0003
N number of cases with IP who develop SCC, duration time between diagnosis of IP and of SCC, expected
expected cases of SCC, outcome accumulated number of cases, SIR standardised incidence ratio, SIRL SIR
lower, SIRU SIR upper, p p value
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Our finding that only men with IP developed SCC has
not been described earlier. To verify if this discrepancy
between genders is true, larger cohort studies are needed.
When considering the risk of SCC in the whole IP cohort,
we should have found approximately five cases of SCC in
the female population. In the review of the English litera-
ture conducted by Nudell et al. [10], 11 out of 59 cases of
SCC ex IP occurred in women.
In the literature, synchronous SCC has previously been
reported to be more common than metachronous malignant
transformation [19]. In a meta-analysis including more than
2000 cases from 2007, Mirza and co-workers found a risk
of 7.1 % of synchronous carcinomas compared with a risk
of 3.6 % of metachronous malignancies [11]. Interestingly
in our study, metachronous cancers were more than four
times as common as the synchronous ones. A similar
proportion was seen in only 4 of the 64 studies in the meta-
analysis. Differing rates found in these earlier studies may
be exaggerated due to referral bias to tertiary centres.
Again, the difference in findings could be due to underre-
porting by the pathologist of IP when SCC is found in the
same specimen. This needs to be investigated further.
Conclusion
In this first population-based study, the incidence of IP has
increased from 0.01 to 0.33/100,000 py in Sweden from
1960 to 2010. The risk of SCC malignancies in the IP cohort
is lower than in the previous studies although significantly
higher than in the general population. Interestingly, we only
found SCC among male patients with IP where the risk of
malignant transformation represented a 300-fold increased
risk compared with the general male population.
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